The framework of pathology: Good laboratory practice by quantitative and molecular methods

Journal of Pathology

Volumn 198, Issue 3, 2002, Pages 277-283

  Baak, Jan P A ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Good laboratory practice; Implementation; Innovation; Pathology

Indexed keywords

COLLAGEN;

ACCURACY; ARTICLE; CLINICAL PRACTICE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FOURIER ANALYSIS; GOOD LABORATORY PRACTICE; IMAGE ANALYSIS; LABORATORY TEST; LEADERSHIP; MEDICAL EXPERT; PATHOLOGIST; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SATISFACTION;

CLINICAL LABORATORY TECHNIQUES; DIFFUSION OF INNOVATION; FOURIER ANALYSIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROSCOPY, CONFOCAL; PATHOLOGY, CLINICAL;

EID: 0036840840     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1233     Document Type: Article

References (28)

1. Zuijlen PPM, de Vries HJC, Lamme EN, et al. Morphometry of dermal collagen orientation by Fourier analysis is superior to multi-observer assessment. J Pathol 2002; 198: 284-291.
2. Brakenhoff GJ, van der Voort HT, van Spronsen EA, Nanninga N. Three-dimensional imaging by confocal fluorescence microscopy. Ann N Y Acad Sci 1986; 483: 405-415.
3. Bartels PH, Baak JPA, Smith J. Laser scanning microscopy. In Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis. Springer: Berlin, 1991; 113-133.
4. Zhu Q, Tekola P, Baak JPA, Beliën JA. Measurement by confocal laser scanning microscopy of the volume of epidermal nuclei in thick skin sections. Anal Quant Cytol Histol 1994; 16: 145-152.
5. Tekola P, Baak JPA, Ginkel AHM van, et al. Three dimensional confocal laser scan DNA ploidy cytometry in thick histological sections. J Pathol 1996; 180: 214-222.
6. Linke R, Muenzing W, Hahn K, Tatsch K. Evaluation of gastric motility by Fourier analysis of condensed images. Eur J Nucl Med 2000; 27: 1531-1537.
7. Chaudhuri S, Nguyen H, Rangayyan RM, Walsh S, Frank CB. A Fourier domain directional filtering method for analysis of collagen alignment in ligaments. IEEE Trans Biomed Eng 1987; 34: 509-518.
8. de Vries HJ, Enomoto DN, van Marle J, van Zuijlen PP, Mekkes JR, Bos JD. Dermal organization in scleroderma: the fast Fourier transform and the laser scatter method objectify fibrosis in nonlesional as well as lesional skin. Lab Invest 2000; 80: 1281-1289.
9. Dybkær R, Jordal R, Jørgensen PJ, et al. A quality manual for the clinical laboratory - including elements of a quality system. Proposed guidelines. Scand J Clin Lab Invest 1992; 52(Suppl): 1-27.
10. Haroske G, Baak JP, Danielsen H, et al. Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal Cell Pathol 2001; 23: 89-95.
11. Bosman FT. Dysplasia classification: pathology in disgrace? J Pathol 2001; 194: 143-144.
12. Baak JPA, Langley FA, Talerman A, Delemarre JFM. The prognostic variability of ovarian tumor grading by different pathologists. Gynecol Oncol 1987; 27: 166-172.
13. Tosoni I, Wagner U, Sauter G, et al. Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. Br J Urol Int 2000; 85: 48-53.
14. Baak JPA, Langley FA, Talerman A, Delemarre JFM. Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing. Anal Quant Cytol Histol 1986; 8: 354-357.
15. Verhaege E, Grosshans E, Haneke E, Piérard G, Ruiter D, Naeyaert J-M. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 2002; 196: 459-466.
16. Mutter GL, Baak JPA, Crum CP, Richart RM, Ferenczy A, Faquin WC. Endometrial precancer diagnosis by histopathology, clonal analysis and computerized morphometry. J Pathol 2000; 190: 462-469.
17. Schnitt SJ, Connolly JL, Tavassoli FA, et al. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992; 16: 1133-1143.
18. Sloane JP, Amendoeira I, Apostolikas N, et al. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. Hum Pathol 1998; 29: 1056-1062.
19. Sudbø J. Pathology in disgrace? J Pathol 2002; 196: 244-245.
20. Sudbo J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001; 344: 1270-1278.
21. Kaern J, Trope CG, Kristensen GB, Abeler VM, Pettersen EO. DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary. Int J Gynecol Cancer 1993; 3: 349-358.
22. Genest DR. Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol 2001; 20: 315-322.
23. Baak JP, Orbo A, van Diest PJ, et al. Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias. Am J Surg Pathol 2001; 25: 930-935.
24. Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 2001; 32: 379-388.
25. Polkowski W, Baak JPA, Lanschot JJB van, et al. Clinical decision making in Barrett oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation. J Pathol 1998; 184: 161-168.
26. van Sandick JW, Baak JP, van Lanschot JJ, et al. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus. J Pathol 2000; 190: 177-183.
27. Baak JPA, van Diest PJ, Fleege JC. Morphometric and combined morphometric-DNA cytometric applications. In Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis. Springer: Berlin, 1991; 269-450.
28. Leyland-Jone B. Trastuzumab: hopes and realities. Rev Lancet Oncol 2002; 3: 137-144.